Innovations in Stroke Prevention: Carotid Stenting Update

OR-Live.com presents Innovations in Stroke Prevention: An Update in Carotid Stenting. The webcast will feature William A. Gray, MD, an interventional cardiologist and Director of Endovascular Care at NewYork-Presbyterian/Columbia University Medical Center, who was the national Principle Investigator of the ARCHeR (ACCULINK for Revascularization of Carotids in High Risk Patients) trial, proving the efficacy of filtered stenting in high-risk endarterectomy patients and ultimately resulting in the first carotid stent system ever approved in the US. His many research credits in this field include his work on the interventional management committee of the NIH- and NHLBI-sponsored trial, CREST (Carotid Revascularization Endarterectomy vs. Stenting Trial), which will randomize 2500 patients between stenting and endarterectomy in the US and Canada. CREST, which will be concluded sometime in 2008, is studying stenting in patients with standard surgical risk, a population that represents perhaps 70% of those undergoing endarterectomy.